Angiotensin, LDL peroxidation and atherosclerosis

Life Sciences

Volumn 63, Issue 1, 1998, Pages 1-11

  Keidar, Shlomo ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Angiotensin; Atherosclerosis; LDL; Oxidation

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN E; BRADYKININ; CAPTOPRIL; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOSARTAN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MALONALDEHYDE; MONOCYTE CHEMOTACTIC PROTEIN; NITRIC OXIDE; PEROXIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEOGLYCAN; QUINAPRIL; RENIN;

ATHEROSCLEROSIS; DOSE RESPONSE; GENE; HEART INFARCTION; HUMAN; HYPERTENSION; INCIDENCE; LIPID PEROXIDATION; NONHUMAN; PLASMA RENIN ACTIVITY; RECEPTOR BINDING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SHORT SURVEY;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ARTERIOSCLEROSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPERTENSION; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MACROPHAGES; MICE; RECEPTORS, LDL;

EID: 0032577338     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00014-9     Document Type: Short Survey

References (47)

1. 1. J.H. LARAGH and J.E. SEALEY, Hypertension: pathophysiology, diagnosis, and management, J.H. Laragh and B.M. Brenner (Eds.), 1813-1836, Raven Press, New York (1995).
2. 2. H. URATA, H. NISHIMURA and D. GANTEN, Am. J. Hypertens. 9 277-284 (1996).
3. 3. V.J. DZAU, Circlation 77 (Suppl I) I-4-I-12 (1988).
4. 4. D.J. CAMPBELL, J Clin. Invest. 79 1-6 (1987).
5. 5. K. LINDPAINTNER and D. GANTEN, Circ. Res. 68 905-921 (1991).
6. 6. T. KITAZONO, R.C. PADGETT, M.L. ARMSTRONG, P.K. TOMPKINS and D.D. HEISTAD, Circulation 91 1129-1134 (1995).
7. 7. N. IWAI, T. INAGAMI, N. OHMICHI and M. KINOSHITA, Hypertension 27 399-403 (1996).
8. 8. M.J. DAEMEN, D.M. LO, F.T. BOSMAN and S.M. SCHWARTZ, Circ. Res. 68 450-456 (1991).
9. 9. H.W. FARBER, D.M. CENTER and S. ROUNDS, Circ. Res. 57 898-902 (1985).
10. 10. A.W.A. HAHN, U. JONAS, F.R. BUHLER and T.J. RESINK, FEBS Lett. 347 178-180 (1994).
11. 11. D.E. VAUGHAN, S.A. LAZOS and K. TONG, J. Clin. Invest. 95 995-1001 (1995).
12. 12. D.M. KERINS, Q. HAO and D.E. VAUGHAN, J. Clin. Invest. 96 2515-2520 (1995).
13. 13. P.M. RIDKER, C.L. GABOURY, P.R. CONLIN, E.W. SEELEY, G.H. WILLIAMS and D.E. VAUGHAN, Circulation 87 1969-1973 (1993).
14. 14. T.J. MOORE, T. TAYLOR and G.H. WILLIAM, J. Clin. Endocrinol. Metab. 58 778-782 (1984).
15. 15. S.L. SWARTZ and T.J. MOORE, Thromb. Haemost. 63 87-90 (1990).
16. 16. S. KEIDAR, J. OIKNINE, A. LEIBA, C. SHAPIRA, M. LEIBA and M. AVIRAM, J. Cardiovasc. Pharmacol. 17 183-186 (1996).
17. 17. F. DIET, R.E. PRATT, G.J. BERRY, N. MOMOSE, G.H. GIBBONS and V.J. DZAU, Circulation 94 2756-2767 (1996).
18. 18. M. ZAMBETIS-BELLESIS, G.J. DUSTING, F.A. MENDELSOHN and K. RICHARDSON, Clin. Exp. Pharmacol. Physiol. 18 337-340 (1991).
19. 19. W.L. BAILEY, D.W. LAFLEUR, J.S. FORRESTER, J.A. FAGIN and B.G. SHARIFI, Atherosclerosis 111 55-64 (1994).
20. 20. S. KEIDAR and J. ATTIAS, Biochem. Biophys. Res. Commun. 239 63-67 (1997).
21. 21. P. HAMET, P. MOREAU, T.V. DAM, S.N. ORLOV, B.S. TEA, D. DE BLOIS and J. TREMBLAY, J. Hypertens Suppl 14 s65-70 (1996).
22. 22. E. CIGOLA, J. KAJSTURA, B. LI, L.G. MEGGS and P. ANVERSA, Exp. Cell Res. 231 363-371 (1997).
23. 23. D. STEINBERG, Circulation 95 1062-1071 (1997).
24. 24. M. AVIRAM, Atherosclerosis 98 1-9 (1993).
25. 25. S. KEIDAR, M. KAPLAN, C. SHAPIRA, J.G. BROOK and M. AVIRAM, Atherosclerosis 107 71-84 (1994).
26. 26. E. MARCHESI, P. BOGNETTI, A. MARTIGNONI, M. MOSCOTTO, B. TRAVERSA and V. RAVETTA, Free Radicals, Lipoprotein Oxidation and Atherosclerosis 305-325 (1995).
27. 27. M.H. ALDERMAN, S. MADHAVAN, W.L. OOI, H. COHEN, J.E. SEALEY and J.H. LARAGH, N. Engl. J. Med. 324 1098-1104 (1991).
28. 28. S.K. WILSON, Circ. Res. 66 722-734 (1990).
29. 29. K.K. GRIENDLING, C.A. MINIERI, J.D. OLLERENSHAW and R.W. ALEXANDER, Circ. Res. 74 1141-1148 (1994).
30. 30. S. RAJAGOPALAN, S. KURZ, T. MUNZEL, M. TARPEY, B.A. FREEMAN, K.K. GRIENDLING and D.G. HARRISON, J. Clin. Invest. 97 1916-1923 (1996).
31. 31. S. KEIDAR, J.G. BROOK and M. AVIRAM, NIPS 8 245-248 (1993).
32. 32. S. KEIDAR, M. KAPLAN, A. HOFFMAN and M. AVIRAM, Atherosclerosis 115 201-215 (1995).
33. 33. P.S. PRABHA, U.N. DAS, R. KORTKAR, P. SANGEETHA SAGAR and G. RAMESH, Prostaglandin Leukotrienes Essentential Fatty Acids 41 27-33 (1990).
34. 34. J.L. WITZTUM and D. STEINBERG, J. Clin. Invest. 88 1785-1792 (1991).
35. 35. S. KEIDAR, M. KAPLAN and M. AVIRAM, Arterioscler. Thromb. Vasc. Biol. 16 97-105 (1996).
36. 36. A. CHOBANIAN, C. HANDENSCHILD, C. NICKERSON and R. DRAGO, Hypertension 15 327-331 (1990).
37. 37. G. ABERG and P. FERRER, J. Cardiovasc. Pharmacol. 15 565-572 (1990).
38. 38. P. CHARPIOT, P.H. ROLLAND and A. FRIGGI, Arterioscler. Thromb. 13 1125-1138 (1993).
39. 39. M. KOWALA, R. GROVE and G. ABERG, Atherosclerosis 108 61-72 (1994).
40. 40. P.H. ROLLAND, T. SOUCHET and A. FRIGGI, J. Hypertens. 9 s178-s179 (1991).
41. 41. R.C. SHARMA, D.W. CRAWFORD, D.M. KRAMSCH, A. SEVANIAN and Q JIAN, Arterioscler. Thromb. 12 403-415 (1992).
42. 42. M. HERNANDEZ-PRESA, C. BUSTOS, M. ORTEGO, J. TUNON, G. RENEDO, M. RUIZ-ORTEGA and J. EGIDO, Circulation 95 1532-1541 (1997).
43. 43. A. PLUMP, J. SMITH, T. HAYEK, K. AALTO-SETALA, A. WALSH, J. VERSTUYFT, E.M. RUBIN and J.L. BRESLOW, Cell 71 343-353 (1992).
44. 44. S.H. ZHANG, R.L. REDDICK, J. PIEDRAHITA and N. MAEDA, Science 258 468-471 (1992).
45. 45. T. HAYEK, J. OIKNINE, J.G. BROOK and M. AVIRAM, Biochem. Biophys. Res. Commun. 201 1567-1574 (1994).
46. 46. T. HAYEK, J. ATTIAS, J. SMITH, J.L. BRESLOW and S. KEIDAR, J. Cardiovasc. Pharmacol. in press (1998).
47. 47. S. KEIDAR, J. ATTIAS, J. SMITH, J.L. BRESLOW and T. HAYEK, Biochem. Biophys. Res. Commun. 236 622-625 (1997).